MedInTech raises KRW 33.8bn Series C for robotic endoscopes, reports say

Seoul-based MedInTech, maker of the motorised AI endoscope INTION S, has taken in KRW 33.8 billion of a Series C round co-led by Atinum Investment and KB Investment, Edaily and Venture Square reported on Nov 17, citing the company.
The money arrived on Nov 2 and Nov 13, the round is to close with more investors before year-end, and cumulative funding is about KRW 62.2 billion. The company has not posted the round on its own website; the figures are unconfirmed by a primary document.
MedInTech, a Seoul startup that motorises gastrointestinal endoscopes, has completed payment of KRW 33.8 billion in a Series C round, Edaily and Venture Square reported on Nov 17, citing the company. According to Edaily, the money was paid in on Nov 2 and Nov 13, and the company plans to bring in more investors before the end of the year before closing the round. MedInTech's own news page had not posted the round when MEKAWIRE checked it on Nov 17, so the figures below rest on the two reports.
Both outlets name existing investor Atinum Investment and newcomer KB Investment as co-leads. Smilegate Investment, SL Investment, ICF (Nextrans) and Woosin Venture Investment followed on, and K2 Investment Partners joined as a new investor. Both reports put earlier rounds at KRW 8 billion for the Series A in 2022 and KRW 20 billion for the Series B in 2024, and cumulative funding at about KRW 62.2 billion.
From motorised scopes to surgical robots
MedInTech's main product is the INTION S, which replaces the manual wire pulling of a conventional endoscope with motor-based control. Venture Square reports that a trial of 178 adults at Seoul National University Hospital found the device non-inferior to a mechanical endoscope on key handling measures, with results published in Scientific Reports. The reports say the INTION S has been supplied to the National Fire Agency hospital and Ajou University Hospital through distributor DK Healthcare, with early sales in Thailand, the Philippines and Mongolia. The company also sells INTION DEEPEYE, software that helps detect and classify lesions in endoscopy video.
The new money is meant for a wider scope line-up, development of robots for internal medicine and surgery, approvals at home and abroad and a mass-production setup, according to the reports. Venture Square adds that a KRW 22.8 billion multi-ministry medical device R&D project the company won in April is separate from the round.
What the round numbers add up to
- Series A
- 2022
- 8.0
- not stated in the reports
- Series B
- 2024
- 20.0
- not stated in the reports
- Series C (paid in so far)
- 2026
- 33.8
- Atinum Investment, KB Investment
- Sum of the three rounds
- No data
- 61.8
- MEKAWIRE calc.
- Cumulative total as reported
- No data
- about 62.2
- No data
Series A and Series B amounts also appear in MedInTech's own Series B announcement on its website, which mentions a 2020 seed round as well; the Series C amount and the cumulative total come from Edaily and Venture Square reports of Nov 17, 2026, citing the company.
As of Nov 17, 2026
The three rounds the reports itemise add up to KRW 61.8 billion, so about KRW 0.4 billion of the reported KRW 62.2 billion total is not explained by them (MEKAWIRE calc.). The Series C is 1.69 times the Series B and 4.2 times the Series A (MEKAWIRE calc.). Neither report gives revenue or a valuation.
MEKAWIRE analysis
MedInTech is raising surgical-robot money on the back of a diagnostic product: investors are paying for the step from motorised scopes to flexible endoluminal surgery, which the company has not yet shown.
The counter-argument is that the INTION S already has hospital customers, a published trial and export sales. The open questions are how much the round finally reaches, whether the company publishes revenue, and when a surgical prototype appears.
What to watch: the final close of the Series C before year-end, any regulatory filing for a treatment or surgical device, and export approvals beyond the three early markets. Company page: MedInTech.
- Atinum Investment, KB Investment
- 178 adults, Seoul National University Hospital (reported)
- KRW 33.8bn (reported)
- about KRW 62.2bn (reported)
- 3: Thailand, Philippines, Mongolia (reported)
- KRW 22.8bn, selected April (reported)
- 1.69x (MEKAWIRE calc.)